Skip to content

Drug interactions

Tofacitinib + Tucatinib

Severity: Major

Tofacitinib and Tucatinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tucatinib inhibits CYP3A4 and may increase tofacitinib exposure. Higher levels increase the risk of infection and cytopenias.

What this interaction means in plain words

Tofacitinib and Tucatinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Tofacitinib belongs to Musculoskeletal; Tucatinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Inhibition of CYP3A4-mediated tofacitinib metabolism.

What to do

Reduce the tofacitinib dose as recommended for CYP3A4 inhibitors. Monitor for infection and blood count changes.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Tofacitinib and Tucatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Tofacitinib with Tucatinib?

MediHelp rates the interaction as major. Tofacitinib and Tucatinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Tucatinib inhibits CYP3A4 and may increase tofacitinib exposure. Higher levels increase the risk of infection and cytopenias.

How serious is the interaction between Tofacitinib and Tucatinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Reduce the tofacitinib dose as recommended for CYP3A4 inhibitors. Monitor for infection and blood count changes.

What other medicines interact with Tofacitinib?

MediHelp also lists interactions of Tofacitinib with, for example, Baricitinib, Cladribine, Upadacitinib. The full list is on the Tofacitinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in